LinkedIn Advertising Privacy Class Action Investigation: What LinkedIn Members Should Know

LinkedIn faces a $6.625M settlement over inflated ad metrics and separate lawsuits alleging it tracked users' medical data for targeted advertising.

LinkedIn members should know that the platform faces multiple class action lawsuits over privacy violations and deceptive advertising practices. The most significant settlement to date involves a $6.625 million agreement resolving claims that LinkedIn inflated advertising metrics for more than 418,000 customers from January 2015 through May 2023—a problem that affected real advertiser budgets and campaign performance. Beyond the ad metrics case, three active lawsuits allege that LinkedIn embedded tracking pixels (the LinkedIn Insight Tag) on healthcare websites to collect sensitive medical information about visitors, including details about fertility treatments, mental health therapy, and urgent care visits, then sold that data for targeted advertising purposes.

These investigations expose a pattern of data collection practices that went beyond user expectations. While most advertising complaints have been addressed through the settlement framework, the healthcare privacy cases represent ongoing allegations of much more invasive tracking—monitoring people’s health conditions without their knowledge as they visit medical provider websites. For LinkedIn members and advertisers, understanding which cases apply to you, what rights you have, and how to participate in settlements or file claims is essential to protecting your interests.

Table of Contents

How LinkedIn’s Advertising Metrics Bug Affected Over 400,000 Advertisers

In November 2020, linkedin disclosed that software bugs had systematically inflated advertising performance metrics for more than two years. The core problem: LinkedIn’s system counted video views even when videos played off-screen as users scrolled through their feeds. This meant advertisers paid for views that weren’t actually watched by real people. The bug resulted in over 418,000 individual overcharges across the platform, ranging from small discrepancies to significant cumulative billing errors. The U.S.

District Court for the Northern District of California approved the settlement on January 28, 2025, making it officially effective on March 1, 2025. Eligible advertisers include any U.S.-based company that purchased advertising through LinkedIn Marketing Solutions between January 1, 2015 and May 31, 2023. The settlement provided full account credits to affected customers, and roughly 90% of impacted advertisers received refunds under $25, though some businesses saw larger overcharges accumulate over multiple years of campaigns. To claim compensation, members and businesses can submit documentation through the official settlement website (linkedinadvertisingclassaction.com) beginning 60 days after the March 1, 2025 effective date. One limitation of this settlement: it only addresses the specific metrics bug discovered in 2020 and doesn’t resolve broader questions about how LinkedIn calculates or reports advertising performance metrics generally. The settlement also requires LinkedIn to hire an independent third-party auditor for two years to review ad metrics accuracy going forward—a contractual oversight that some advertisers welcomed as a check on future practices, though others noted it came only after the company had already collected potentially inflated fees for years.

LinkedIn Insight Tag Tracking: Health Data Sold for Targeted Ads

Beyond the advertising metrics case, LinkedIn faces more serious allegations involving the LinkedIn Insight Tag—a JavaScript tracking pixel that the company provides to website owners. When embedded on a website, this pixel silently collects information about every visitor and their behavior, including what pages they view, what buttons they click, and when they convert into customers or clients. The privacy lawsuit claims emerged after researchers discovered that LinkedIn had embedded this tracking pixel on the websites of healthcare providers, collecting deeply sensitive health information without users’ knowledge. Three active cases name specific healthcare companies: Spring Fertility (reproductive health and IVF services), Therapymatch and Headway (mental health therapy platforms), and CityMD and ReflexMD (urgent care and telemedicine). In each case, visitors to these healthcare websites—often people researching or receiving treatment for private medical conditions—were unknowingly tracked by LinkedIn’s pixel. The collected data allegedly included the specific health conditions people were seeking treatment for, their medical histories, and their insurance details.

LinkedIn then used this health data to build targeted advertising profiles, allegedly selling or leveraging this information to healthcare advertisers and pharmaceutical companies seeking to reach people with specific medical needs. A critical warning: Judge Edward J. Davila ruled in October 2025 that plaintiffs adequately pleaded privacy invasion claims under the California Constitution and California Invasion of Privacy Act Section 632—meaning the cases have survived early dismissal attempts and are moving toward discovery and potential trial. However, one similar case brought against Spring Fertility was dismissed because the plaintiff had clicked through the website’s cookies policy, which technically disclosed the tracking. This creates a legal gray area: even if a privacy policy mentions tracking, visitors may not understand that health data collected by third-party pixels will be used for targeted advertising. The case hasn’t gone to trial yet, and a status conference is scheduled for October 23, 2025 to discuss whether the three remaining cases should be consolidated.

LinkedIn Advertising Settlement Impact: Affected Advertisers and Refund DistribuAdvertisers with Under $25 Refunds376620 advertisersAdvertisers with $25-$100 Refunds30546 advertisersAdvertisers with $100-$500 Refunds9216 advertisersAdvertisers with $500+ Refunds1618 advertisersTotal Eligible Advertisers418000 advertisersSource: LinkedIn Advertising Class Action Settlement

Who Is Eligible for the Advertising Metrics Settlement

The $6.625 million settlement only applies to U.S. advertisers who purchased ads through LinkedIn Marketing Solutions during the affected window (January 1, 2015 through May 31, 2023). This includes small businesses, marketing agencies, B2B companies, and enterprises—anyone who ran paid campaigns on LinkedIn’s platform. If you’re a LinkedIn member but never ran ads, or if you only used organic LinkedIn features (posting updates, using LinkedIn Recruiter, participating in groups), you are not eligible for this settlement. Claiming compensation is relatively straightforward for advertisers with documentation. The settlement administrator maintains the website linkedinadvertisingclassaction.com, where you can enter your LinkedIn advertiser account information to check if you’re eligible and the estimated credit amount.

You’ll need either your LinkedIn account login credentials or documentation showing you paid for ads. Processing began 60 days after the March 1, 2025 effective date, so claims started being reviewed in May 2025. The settlement helpline at (877) 411-4976 can help verify eligibility if you have questions about a specific account or campaign. One tradeoff many advertisers faced: LinkedIn distributed refunds as account credits rather than cash refunds. This meant companies couldn’t withdraw the money directly; they had to spend the credit on future LinkedIn advertising. For small businesses or those who had already stopped advertising on the platform by the time they learned about the settlement, this limitation meant the compensation couldn’t be redirected to other uses. The settlement agreement required this approach partly because determining actual damages was complex—it’s difficult to quantify exactly how much harm an inflated view count caused, especially years after the campaign ran.

The LinkedIn Insight Tag Lawsuits and Your Online Privacy

The three active health data privacy lawsuits raise questions that extend beyond just LinkedIn. When you visit a website—whether it’s a doctor’s office, a fertility clinic, a therapy platform, or a medication delivery service—you typically don’t see a notice that LinkedIn’s tracking pixel is there. The pixel operates invisibly, monitoring your behavior on the site and sending information back to LinkedIn’s servers. This is standard practice for many websites that use LinkedIn’s marketing and analytics tools, but the privacy lawsuits argue it crosses an ethical and legal line when the data collected is sensitive health information. One documented example involves Therapymatch, a mental health therapy-matching platform. A visitor to Therapymatch searching for therapists who treat anxiety disorders, depression, or PTSD would be tracked by LinkedIn’s Insight Tag without any explicit consent or disclosure specific to that tracking.

LinkedIn would receive data indicating the visitor was researching mental health treatment. The platform then could—and allegedly did—use this information to build an advertising profile of that person as someone with mental health treatment interests, making them a target for pharmaceutical ads, mental health apps, or wellness services. The visitor never agreed to LinkedIn tracking their health information for advertising purposes. A significant limitation: most website privacy policies are written broadly enough to technically disclose third-party tracking, but most users don’t read privacy policies, and many policies don’t explicitly call out that health data will be tracked by LinkedIn and used for targeted ads. Judge Davila’s ruling acknowledged this gap in his October 2025 decision, finding that plaintiffs had adequately alleged that LinkedIn’s tracking and data use violated California privacy law despite potential technical disclosures buried in policies. The case is still in the early stages, and no settlement has been reached yet, so anyone who visited these healthcare websites during the period when the Insight Tag was active may be part of the potential class.

Other LinkedIn Privacy Investigations and VPPA Claims

Beyond the metrics settlement and health data lawsuits, LinkedIn faces additional class action investigations involving privacy violations and data transmission. One active case alleges LinkedIn violated the Video Privacy Protection Act (VPPA) by knowingly transmitting user information to Facebook and Adobe without consent. The VPPA is a 1988 federal law designed to protect the privacy of video rental data, but courts have extended it to online tracking and data sharing. U.S. District Judge P. Casey Pitts denied LinkedIn’s motion to dismiss this case, allowing it to proceed to discovery. Another recent class action alleges LinkedIn conducted covert browser surveillance under the guise of anti-abuse protection and security monitoring.

The lawsuit, filed in 2026, claims LinkedIn ran scripts in users’ browsers that tracked their online activity across the web without clear consent or disclosure. A separate line of litigation involves allegations that LinkedIn’s aggressive anti-scraping practices and the mechanisms used to enforce them violated privacy law. These cases are ongoing and haven’t reached settlement stages yet, but they paint a broader picture of LinkedIn’s data collection practices extending beyond just advertising and health data. A warning: the outcomes of these cases could have significant consequences for how LinkedIn operates. If plaintiffs prevail in any of these lawsuits, LinkedIn could face additional major settlements, mandatory changes to its tracking practices, or requirements to delete collected data. For LinkedIn members, this means the company’s privacy practices may change materially in the coming years depending on how courts rule. None of these additional cases have been settled, so no compensation is currently available to class members in these investigations.

Court Oversight and LinkedIn’s Auditor Requirements

As part of the $6.625 million settlement agreement, LinkedIn committed to hiring an independent external auditor to review its advertising metrics and reporting practices for two years following the settlement’s effective date (March 1, 2025 through March 1, 2027). This auditor will examine how LinkedIn calculates and reports key performance metrics to advertisers, including view counts, impressions, engagement rates, and conversion attribution. The auditor’s role is to verify that the metrics bugs that led to the 418,000 overcharges have been fixed and that no similar systematic errors are occurring.

This oversight mechanism is intended to prevent a repeat of the 2015–2023 period when the off-screen video view bug went undetected for over two years. However, a limitation is that the auditor’s authority is limited to examining advertiser-facing metrics. The auditor cannot investigate or verify how LinkedIn collects data from users, handles privacy, or uses information for targeting—those broader privacy questions fall outside the settlement’s scope and are the subject of the separate health data privacy lawsuits. Additionally, the auditor reports findings to the court and the settlement administrator, not directly to the public, so full transparency of their reviews is not guaranteed.

Ongoing Considerations for LinkedIn Users and Advertisers

The combination of the metrics settlement, the health data privacy lawsuits, and the additional investigations suggests LinkedIn’s data practices will face increasing regulatory and legal scrutiny through at least 2026 and beyond. For advertisers, this means the platform’s tracking capabilities, metric reliability, and legal standing remain uncertain. Some advertisers have already reduced their LinkedIn advertising spend pending resolution of these cases, while others have implemented stricter internal audits of campaign performance data.

For regular LinkedIn members, the investigations underscore that the platform collects and uses data in ways many users don’t fully understand or expect. The official settlement website (linkedinadvertisingclassaction.com) serves as the central resource for the advertising metrics case. The settlement helpline at (877) 411-4976 and email contact ([email protected]) are available for questions about eligibility or claim filing. For the health data privacy lawsuits, there is no settlement yet, so no claims process is open; however, if you visited any of the named healthcare websites (Spring Fertility, Therapymatch/Headway, CityMD, or ReflexMD) and believe your health data was collected by LinkedIn’s Insight Tag, you may have legal rights once these cases are resolved.


You Might Also Like